Sentence examples for provides considerations from inspiring English sources

This paper provides considerations for SUD system design and development.

This paper reviews elements of past research methodologies of Baduanjin intervention studies and provides considerations for future research.

The present study provides considerations relevant for comparative tobacco product assessments both in the scientific and regulatory contexts.

It demonstrates the feasibility of conducting high-quality clinical trials in CRPS type 1 and provides considerations for designing future trials.

Finally, the chapter provides considerations regarding how the pharmaceutical industry may achieve return-on-investment (ROI) while achieving advanced process control and real-time release (RTR) by capitalizing on manufacturing efficiencies.

This review summarizes the lessons learned from these case studies, evaluates scientific, study design, and business factors that can affect study outcomes, identifies common challenges faced by sponsors developing these innovative therapies, and provides considerations for future study designs that may increase the likelihood of success.

If the clause is included in an initial employment contract, the offer of employment typically provides consideration for the entire contract including the clause.

We also provide considerations for the design of future treatment strategies to be implemented in alternative care settings.

Here, we outline a general approach to rational protein chimera design based on our experience, and provide considerations for the selection of the fragments, the evaluation, and possible redesign of the constructs.

Any good argument can provide the basis for distinguishing, for example by showing that the novel facts in the later case provide considerations which outweigh the original justification: it is not that the original justification is inapplicable to the novel facts, it is simply that those facts raise additional considerations that are more compelling.

The objective of this paper is to provide considerations based on comprehensive case studies important for regulatory evaluation of monoclonal antibodies as similar biotherapeutic products (SBPs) with a special emphasis on clinical aspects.